By Karla Pomeroy
Editor
Protesters question FDA approval of Pfizer vaccine; hospitalizations rise
Share
Tweet
WORLAND — When the Pfizer BioNTechSE COVID-19 vaccine gained full approval from the U.S. Food and Drug Administration last month, the announcement said the vaccine would now be marketed as COMIRNATY®.
The change in the name has created confusion with some questioning the difference between the vaccine granted full approval and the one granted emergency use authorization. One protester at Mon...
For access to this article please
sign in or
subscribe.
